Results
1 -
10 of
23Emerging Small Molecule Drugs, High Density Lipoproteins Statins and CETP Inhibitors: Anacetrapib and Evacetrapib: The Last Hope?, Combination Therapy In Dyslipidemia Newer Agents, Cardiac Drug Therapy Dyslipidemias, Cardiac Drug Therapy Phase III Trial of Dalcetrapib, Pharmaceutical Medicine Bringen die CETP-Hemmer den n??chsten Durchbruch?, MMW - Fortschritte der Medizin Effect of hepatic or renal impairment on the pharmacokinetics of evacetrapib, European Journal of Clinical Pharmacology High-density lipoprotein in uremic patients: metabolism, impairment, and therapy, International Urology and Nephrology LDL-Cholesterin und kardiovaskul??re Ereignisse: je??niedriger desto besser?, Wiener Medizinische Wochenschrift Beyond Statins: New Lipid Lowering Strategies to Reduce Cardiovascular Risk, Current Atherosclerosis Reports